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Abstract 
Knee osteoarthritis is one of the most common causes of chronic pain worldwide, and several animal 
models have been developed to investigate disease mechanisms and treatments to combat associated 
morbidities. Here we describe a novel method for assessment of locomotor pain behavior in Yucatan 
swine. We used monosodium iodoacetate (MIA) to induce osteoarthritis in the hindlimb knee, and then 
conducted live observation, quantitative gait analysis, and quantitative weight-bearing stance analysis. 
We used these methods to test the hypothesis that locomotor pain behaviors after osteoarthritis 
induction would be detected by multiparameter quantitation for at least 12 wk in a novel large animal 
model of osteoarthritis. MIA-induced knee osteoarthritis produced lameness quantifiable by all 
measurement techniques, with onset at 2 to 4 wk and persistence until the conclusion of the study at 12 
wk. Both live observation and gait analysis of kinetic parameters identified mild and moderate 
osteoarthritis phenotypes corresponding to a binary dose relationship. Quantitative stance analysis 
demonstrated the greatest sensitivity, discriminating between mild osteoarthritis states induced by 1.2 
and 4.0 mg MIA, with stability of expression for as long as 12 wk. The multiparameter quantitation used in 
our study allowed rejection of the null hypothesis. This large animal model of quantitative locomotor pain 
resulting from MIA-induced osteoarthritis may support the assessment of new analgesic strategies for 
human knee osteoarthritis. 
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Knee osteoarthritis is the most common cause of chronic pain 
in the United States.15 The morbidity incurred by chronic pain 
and loss of function due to knee osteoarthritis represents the 
most common cause of lower limb disability in patients older 
than 50 y.8 The inadequacy of existing pharmacologic and mini-
mally invasive therapies in addressing this disabling disease 
is evidenced by the ever-rising rates of knee arthroplasty.10,23 
Evolution of new treatment strategies to treat knee osteoarthritis 
will require a suitable large animal model of chronic locomotor 
pain behavior that is quantifiable and affords assessment of an-
algesic, orthopedic, or other novel therapies.
The disability associated with knee osteoarthritis that drives 
knee replacement strategies likely encompasses human dis-
comfort, nociceptive pain, and physical dysfunction.3,5,7,8,10,13,23 A 
large animal model seeking to test analgesic strategies may, at 
best, isolate nociceptive pain from structural dysfunction.11,19-21 
This model would ideally 1) rapidly induce a pain state that is 
2) manifest as a measurable behavior, that 3) remains stable over 
time but can be modulated via a 4) dose–response relationship 
with the inducing agent in a 5) useful large animal species. We 
previously described a large animal model of monosodium io-
doacetate (MIA)-induced osteoarthritis in the hindlimb knee of 
Yucatan swine.28 This species is amenable to behavioral training, 
demonstrates slow and stable growth, and possesses a knee that 
is homologous to the human joint.28 In addition, swine develop 
locomotor abnormalities in association with various degrees of 
clinical pain and therefore provide measurable pain-associated 
behaviors in both clinical and research settings.16,25,27,29
The tissue injury resulting from MIA-induced osteoarthritis 
in the swine knee has been characterized previously by using 
clinical-grade 3-T MRI and gross pathologic examination.28 We 
found that MIA stimulates initial synovitis, manifest as joint 
effusion, followed by progressive cartilage erosion, bone mar-
row edema, and exposure of subchondral bone. Each of these 
changes has been observed in human osteoarthritis and is con-
sidered to be a contributor to chronic, osteoarthritis-related pain 
syndromes.3,5,7,8,24 A relationship between structural injury and 
MIA dose was observed; however, the progression of the disease 
over time was the strongest predictor of tissue injury. Although 
these features are typical for the clinical course of human os-
teoarthritis, they could confound the use of MIA-induced knee 
osteoarthritis in swine as a model of chronic pain if the resulting 
pain behaviors mirrored the tendency for anatomic disease to 
progress in a relentless fashion, as compared with a stable and 
titratable behavioral phenotype.
This study sought to assess MIA-induced locomotor pain in 
Yucatan swine by measuring the onset, severity, and stability 
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Figure 1. Detailed quantification of swine gait by GAITRite (GR) system and data processing. (A) Footfalls contributing to a successful GR run 
for one pig. As the animal trots across the runway (here from left to right), sensors embedded in the runway transmit pressure data to a dedi-
cated laptop computer. GR software logs the time (s), location (m), number of sensors, and pressure received by each sensor. This information 
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of pain behaviors after the induction of knee osteoarthritis. We 
hypothesized that locomotor pain behaviors after osteoarthritis 
induction would be detected by multiparameter quantitation 
for at least 12 wk in a novel large animal model of chronic os-
teoarthritis. Multiple modes of assessment were used, thereby 
allowing testing of functionally related parameters to define 
phenotype stability. Live, subjective lameness evaluation was 
performed by blinded experimenters by using a previously 
validated, large animal scoring system.17 A commercial pres-
sure runway system, GAITRite (GR), was used to record kinetic 
and spatiotemporal gait parameters,9 and an electronic force 
plate (FP) system22 was used to quantify static weight bearing. 
Five dose groups of intraarticular MIA (0, 1.2, 4, 12, and 40 mg 
per knee) were tested to determine whether a dose–response 
relationship allowed the creation of discrete states of locomotor 
behavioral abnormality.
Materials and Methods
Animals. The study was conducted in accordance with the 
Guide for the Care and Use of Laboratory Animals14 and the Mayo 
Clinic IACUC. Female (n = 12) and castrated male (n = 15) Yu-
catan swine (age, 8 to 15 mo) were included in this study. Swine 
were purchased from an institutionally approved vendor (Ex-
emplar Genetics, Sioux Center, IA) from a herd that was free 
of major pathogens. On arrival to the facility, all animals were 
vaccinated against porcine circovirus type 2, Mycoplasma hyo-
pneumoniae, Erysipelothrix rhusiopathiae, and porcine parvovirus. 
Study animals were group-housed indoors in an AAALAC-
accredited facility with controlled temperature (66 ± 5 °F [18.9 
± 2.8 °C]), humidity (30% to 60%), and ventilation (10 to 15 air 
changes hourly). The animals were provided free access to fil-
tered municipal water by using automatic watering devices and 
were fed a commercial swine diet (Pine Island Mayo Gestation, 
Purina Animal Nutrition , Shoreview, MN) twice daily, along 
with a variety of food treats. Swine were monitored daily by vet-
erinary staff and were weighed at least once weekly by using a 
standalone scale. Behavioral analysis extended for as long as 12 
wk in the current study. In addition to institutionally mandated 
endpoints, animals were to be euthanized in cases of uncon-
trolled bleeding, antibiotic-resistant infection, cyanosis, inability 
to drink or eat, or inability to stand or ambulate that did not 
improve clinically after 48 h. Swine that were observed to be 
in overt pain, as evidenced by vocalization during ambulation 
or knee manipulation, were evaluated by a clinical veterinar-
ian to determine appropriate analgesic treatment. Analgesic tri-
als were initiated for 48 to 72 h to test whether symptoms were 
transitory, during which time behavior data were not collected. 
When pain was determined to be unmanageable by analgesic 
therapy, the animal was to be euthanized. To reduce the number 
of animals used for related studies, swine were simultaneously 
enrolled in a separate protocol to study knee imaging and gross 
pathology, where additional animal-specific information includ-
ing weight has been reported.28 Experimental data contained 
herein have not previously been reported.
Osteoarthritis induction. Intraarticular injection of MIA into 
one hindlimb knee was used to induce osteoarthritis. Five dose 
groups were used, as described previously.28 Briefly, the 5 MIA 
dose groups were chosen by scaling the doses previously re-
ported in small animal studies according to the difference in 
total body surface area from rodents to swine.12,19 Doses com-
prising 1.2 (n = 9), 4 (n = 12), 12 (n = 2), or 40 (n = 2) mg MIA dis-
solved in either 2 or 3 mL PBS were injected into one hindlimb 
knee per animal (n = 25) under ultrasound guidance, as previ-
ously described.15 In MIA-injected animals, the contralateral 
hindlimb knee received either PBS (n = 10) or no injection (n = 
15). Control animals (n = 2) received PBS injected into bilateral 
hindlimb knees. All procedures were performed under general 
anesthesia and strict aseptic technique. Anesthesia was induced 
by using intramuscular tiletamine–zolazepam (5 mg/kg), xyla-
zine (2 mg/kg), and glycopyrrolate (0.01 mg/kg). Swine were 
then intubated, and anesthesia was maintained by isoflurane 
(1.5% to 2.5%, titrated to effect) in 50% oxygen. Total duration 
of anesthesia for osteoarthritis induction was 45 to 60 min per 
animal. Animals were monitored continuously, and vital signs 
were documented at least every 15 min for heart rate, respi-
ratory rate, body temperature, ventilation, oxygenation, and 
depth of anesthesia by eliciting reflex responses. The skin over 
both knee joints was surgically clipped and scrubbed with 1% 
chlorhexidine. Under ultrasound guidance, a 23-gauge needle 
was inserted from lateral to medial into the intraarticular, syno-
vial space between the patella and trochlea. A 100-μL PBS test 
injection confirmed dispersion of injectate in the synovial space 
under real-time ultrasound observation. Intraarticular injections 
were performed in a blinded fashion by a musculoskeletal radi-
ologist during week 0 of the study. The side that received MIA 
was assigned randomly, and personnel involved in subsequent 
behavior experiments were blind to the side injected and type 
of injectate.
Lameness scoring through live observation. As previously 
described in ponies6 and swine,17 a large animal-specific, cat-
egorical, 5-point scoring system was used to define and evalu-
ate lameness. Animals were observed during spontaneous 
is used to compute the spatiotemporal and kinetic gait parameters described in Methods. The embedded sensors are located every 1.27 cm 
in 2 dimensions within the runway. Footfalls are plotted according to a Cartesian coordinate system. The x-axis is plotted along the length of 
the runway, parallel to the direction of animal locomotion, and the y-axis is plotted along the runway width, perpendicular to the direction of 
animal locomotion. Derivation of one spatiotemporal parameter, stride length, is depicted as the distance between 2 consecutive footfalls of the 
same foot. The software computes the time for this stride by subtracting the time of a subsequent footfall from the former. Stride velocity was 
computed as stride length divided by stride time. The particular run represented (A) was considered successful because it met the minimum 
required number of sequential footfalls (i.e., 12) after filtering out asynchronous footfalls. The x-axis is truncated to illustrate the selection for 
synchronous footfalls, generally occurring over the center of the runway, which corresponded to a trotting gait. (B) Total scaled pressure (TSP) 
per footfall grouped by run ID number for the complete set of successful GR runs during a representative week for one pig. The footfalls for run 
ID number 3511 correspond to those depicted in panel A. Run ID number was assigned by the software for each new run, beginning when the 
animal first pressurizes an embedded sensor. Missing run ID numbers (locations marked ‘V’) represent unsuccessful runs not included in sub-
sequent analysis due to asynchronous pattern, failure to meet the minimum of 12 consecutive footfalls, or superfluous runway activation by the 
animal. (C) Mean TSP per limb grouped by run ID number for all successful GR runs during the representative week depicted in panel B. A total 
of 13,220 successful GR runs comprising 116,008 hindlimb footfalls were included in this study. (D) Graphical key corresponding to quadruped 
limbs. Limbs are named according to laterality and relative position along the rostrocaudal (head to tail) axis. Forelimbs are shown in gray, with 
the left forelimb (LF) as a circle, and the right forelimb (RF) as a diamond. Hindlimbs are shown in color, with the left hindlimb (LH) as a blue 
square, and the right hindlimb (RH) as a red triangle. (E) Fold change in weekly TSP hindlimb kinetic weight-bearing ratios for one pig in the 
highest dose group (40 mg MIA). Data points depict the means for all successful runs obtained in a given week. Error bars, ± 1 SD from the mean.
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exploration on level, dry ground without obstacles for 5 min, 
and lameness was scored once daily 5 times each week by a 
veterinary technician trained in the scoring system. Individual 
lameness scores were defined as: 0, pig moves freely and uses all 
4 limbs and feet evenly; 1, animal shows weight-shifting activi-
ties away from affected limb on standing but shows little or no 
lameness or limping when walking; 2, pig overtly shifts weight 
away from affected limb when standing and shows limping or 
adaptive behavior (e.g., head bob, quickened step) on affected 
limb when walking; 3, animal is reluctant to stand or walk and 
shows obvious limping and adaptive behaviors when walking; 
and 4, pig is nonweight-bearing on the affected limb when ei-
ther standing or walking. A lameness score of 1 was considered 
to be consistent with mild lameness, scores of 2 and 3 as mod-
erate lameness, and a score of 4 as severe lameness. Baseline 
lameness scores were collected over 3 wk prior to osteoarthritis 
induction.
Gait analysis. Quadrupedal gait was quantified during am-
bulation on level, dry ground without obstacles. Gait data were 
captured by using the GAITRite Electronic Walkway and soft-
ware (CIR Systems, Sparta, NJ),9 The GR system consisted of 
a rubber runway with embedded sensors connected to a com-
puter. The runway measured 4.9 m × 0.6 m × 0.3 cm. For 3 ses-
sions prior to collection of baseline experimental data, pigs were 
acclimated and subsequently trained to trot from one end of 
the runway to the other, by using positive reinforcement in the 
form of food rewards. Baseline gait parameters were collected 
over 3 wk prior to osteoarthritis induction. The GR software re-
corded and calculated gait parameters per footfall in sessions as 
long as 15 min. After each session, raw GR data were processed 
to remove unsuccessful runs. The video acquired during each 
run was used to manually assign footfall data to corresponding 
limbs within the software. Footfalls were then considered with 
regard to their sequence and speed, and only those runs that 
demonstrated a trotting gait rhythm22 and contained at least 12 
consecutive footfalls were considered successful and were used 
for subsequent analysis. Runs that did not demonstrate the trot-
ting form or contained fewer than 12 consecutive footfalls were 
removed from subsequent analysis, thereby retaining only those 
runs with a consistent speed and rhythm. The direction of a run 
across the GR runway, for example, from left to right, was not 
a factor in determining whether a given run was considered 
successful. The GR software was used to compile a database 
of spatiotemporal gait parameters for each footfall, including 
stride length, stride time, stance time, and swing time, and the 
kinetic parameters of number of sensors and mean pressure. 
Stride velocity was calculated as stride length divided by stride 
time. Total scaled pressure (TSP), indicative of kinetic weight 
bearing, was calculated by multiplying the number of sensors 
and mean pressure per footfall. Each sensor measured the force 
transmitted to the GR runway over an area of 1.613 cm2. Thus, 
the computed total pressure was scaled to the minimal area of 
detection per sensor. Kinetic weight-bearing values reported in 
Results for each week represent the mean fold change in TSP 
hindlimb ratio (MIA-injected hindlimb:contralateral control 
hindlimb) per dose group after mean values were calculated 
for each successful run per animal. A graphic depiction of data 
capture and handling is shown in Figure 1.
Static weight-bearing asymmetry. Static weight bearing was 
quantified for each hindlimb by using the Iowa State Univer-
sity FP system and software (Figure 2).17,22 For 3 sessions prior 
to collection of baseline experimental data, positive reinforce-
ment training in the form of food rewards was used to train ani-
mals to freely walk onto the FP system and stand with one foot 
Figure 2. Force plate analysis of static weight-bearing asymmetry. The force plate apparatus and enclosure are shown from the (A) rear and 
(B) side views. Animals were encouraged to enter the enclosure and stand on the force plate during the scheduled morning mealtime. Swine 
chow was provided in the centrally positioned holster (arrow). Each limb was positioned on 1 of 4 force plate platforms corresponding to the 
left forelimb, right forelimb, left hindlimb, and right hindlimb while weight-bearing data was captured. Each animal was allowed as long as 15 
min per session.
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on each of the 4 force plates. The individual force plates were 
connected to a dedicated laptop computer. The FP software re-
corded the weight transmitted to each plate at a frequency of 2 
measurements per second. FP sessions lasted a maximum of 15 
min, and pigs continually received food rewards throughout 
each session. A blinded experimentalist gently corrected the 
animal by guiding limbs to the appropriate plate when a given 
limb deviated from the correct position. After each session, FP 
data were processed to remove measurements corresponding to 
limb deviation and during periods of animal mounting and dis-
mounting from the FP system. The resulting FP data, reported 
by the software as vertical ground reaction force per limb, were 
divided by total body weight to yield static weight bearing per 
limb as a percentage of total body weight. We assumed that 
force transmission would be almost entirely along the vertical 
axis without significant loss to another vector, because animals 
were stationary during static weight-bearing data acquisition. 
FP analysis became available during the course of the study, 
limiting its use to data collection for the lower dose groups of 
1.2 and 4 mg MIA. Baseline static weight-bearing parameters 
for these cohorts were collected over 3 wk prior to osteoarthritis 
induction.
Statistics. For all behavioral modalities, values represent 
the mean ± 1 SEM per dose group for each study week,. Data 
obtained prior to intervention are represented graphically 
throughout the study during week –1. To assess the significance 
of various factors on the severity of observed pain-associated 
behaviors, a multivariate, ANOVA-type analysis with time as re-
peated measures, MIA dose group as fixed effect, and combined 
‘MIA dose group:time’ as interaction effect was performed by 
using the function LMER in R. This analysis was conducted ac-
cording to previously described methods.28 The Tukey multiple 
comparison test was used to determine statistically significant 
differences between dose groups for lameness scores, GR data, 
and FP data each week. FP static weight-bearing data were com-
pared by using the Student t test to determine statistically sig-
nificant differences within dose groups between paired values 
obtained from the MIA-injected hindlimb and the contralateral 
noninjected hindlimb. For all statistical analyses, a P value of 
less than 0.05 was considered significant.
Results
Association between MIA-induced osteoarthritis and persistent 
and stable lameness. All pigs demonstrated symmetric gait and 
stance during live observation prior to osteoarthritis induction 
(Figure 3). In the 40-mg dose group, lameness was first observed 
during week 2 and remained significantly (P < 0.001) different 
from controls for the remainder of the study. Beginning at week 
4, lameness scores for the 12-mg dose group were comparable to 
Figure 3. Severity and progression of lameness measured during live observation is correlated to monosodium iodoacetate (MIA) dose. Time 
series depicts lameness scores before and after osteoarthritis induction (study week 0). Individual data points represent the weekly mean lame-
ness score per dose group. Dose groups are indicated by color as follows: blue, control (0 mg, n = 2); red, 1.2 mg MIA (n = 9); green, 4 mg MIA 
(n = 12); violet, 12 mg MIA (n = 2); orange, 40 mg MIA (n = 2). Lameness scores reflect overall animal lameness irrespective of injection laterality. 
Control animals did not receive a score greater than 0 at any time point. All data points displayed below the zero line (gray) reflect a score of 0. 
Error bar, ± 1 SEM. Tukey multiple comparison test, ‡, P < 0.001.
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the 40 mg dose group (P ≥ 0.28 at all time points), and this rela-
tionship was sustained throughout the study until the primary 
endpoint (week 12). A minority of animals in the 4-mg group 
(n = 4) demonstrated transient lameness during weeks 1 and 2, 
which became significant compared with controls by week 3 (P 
< 0.001) and persisted for the remainder of the study. The 1.2-mg 
cohort remained visually unaffected and indistinguishable from 
control animals throughout the study (P = 0.999).
MIA-induced osteoarthritis caused visually distinguish-
able changes in qualitative gait and stance behaviors in swine 
compared with baseline and control animals (Figure 3). Al-
though the lowest dose tested did not result in overt lameness, 
the remaining dosage groups exhibited persistent gait and 
stance aberrations that stabilized by week 4. Severity of osteo-
arthritis-specific lameness during this time period was either 
mild (4-mg group) or moderate, with the moderate phenotype 
composed of animals that received either 12 or 40 mg MIA.
Quantitative gait analysis. Kinetic weight bearing measured 
from MIA-injected and control hindlimbs in the 40-mg dose 
group demonstrated a significant (P < 0.001) difference at 2 
Figure 4. Dose-dependent decrease in kinetic weight bearing of monoiodoacetate (MIA)-injected hindlimbs. Time series depicts fold change 
in kinetic weight bearing before and after osteoarthritis induction (study week 0). Individual data points represent the weekly mean kinetic 
weight-bearing value per dose group. Dose groups are indicated by color as follows: blue, control (0 mg, n = 2 hindlimb pairs); red, 1.2 mg MIA 
(n = 9 hindlimb pairs); green, 4 mg MIA (n = 12 hindlimb pairs); and violet, 12 mg MIA (n = 2 hindlimb pairs); orange, 40 mg MIA (n = 2 hindlimb 
pairs). Kinetic weight bearing was calculated as the total scaled pressure (TSP) ratio between the MIA-injected hindlimb and contralateral con-
trol hindlimb per animal within dose groups. Errors bar, ± 1 SEM. Tukey multiple comparison test, ‡, P < 0.001.
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wk after osteoarthritis induction, similar to observed overt 
lameness (Figure 4). Of note, the rise in lameness within the 
4-mg dose group during week 3 (Figure 3) did not coincide 
with decreased weight bearing recorded by the GR system 
(Figure 4). Decreased weight bearing in the 12-mg dose group 
was observed by week 3 (Figure 4), 1 wk earlier than that 
observed by lameness scoring alone. The decrease in weight 
bearing demonstrated by the 4-, 12-, and 40-mg MIA-injected 
Figure 5. Spatiotemporal gait parameters are unaffected by monosodium iodoacetate (MIA)-induced osteoarthritis in swine. (A and B) Stance 
time (s), (C and D) swing time (s), and (E and F) stride velocity (m/s) are depicted as weekly mean values per dose group. (A, C, E) Control 
hindlimb contralateral to (B, D, F) MIA-injected hindlimb of each animal is depicted. Both hindlimbs of control animals (n = 2 animals, n = 4 
hindlimbs) are represented in panels A, C, and E. Individual data points represent weekly mean values per dose group obtained for a single 
hindlimb per animal. Dose groups are indicated by color as follows: blue, control (0 mg, n = 2 animals); red, 1.2 mg MIA (n = 18 hindlimbs); 
green, 4 mg MIA (n = 24 hindlimbs); violet, 12 mg MIA (n = 4 hindlimbs); and orange, 40 mg MIA (n = 4 hindlimbs). Errors bar, ± 1 SEM. Study 
week 0 corresponds to the time of MIA injection. No trend correlating any relationship between MIA dose or time and the spatiotemporal pa-
rameters depicted was observed.
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hindlimbs suggested a dose relationship by week 6 (Figure 4, 
P < 0.001), approximately 2 wk later than was observed accord-
ing to lameness scores. Control and 1.2-mg dose groups were 
indistinguishable through gait analysis throughout the study 
(Figure 4).
Kinetic weight bearing measured by GR revealed that the 
4-mg dose group demonstrated a stable, mild osteoarthritis phe-
notype between weeks 6 to 12 relative to the moderate osteoar-
thritis phenotype observed for the 12- and 40-mg doses over the 
same time period (Figure 4). All spatiotemporal gait parameters 
derived from GR data, including stance time, swing time, and 
stride velocity, did not reveal any significant differences from 
controls throughout the study period (Figure 5).
FP analysis. Static weight-bearing values obtained for the 
1.2- and 4-mg dose groups demonstrated a significant differ-
ence between MIA-injected hindlimbs and contralateral con-
trol hindlimbs as early as week 1 after osteoarthritis induction 
(Figure 6). For the lowest dose group (1.2 mg), static weight-
bearing asymmetry between hindlimbs was significant (P < 
0.05) throughout the study except during weeks 2 and 7 (Figure 
6). The final 2 wk of the study revealed increased and signifi-
cant (P < 0.01) asymmetry. As demonstrated by lameness scores 
(Figure 3) and kinetic weight-bearing measurements (Figure 4), 
the 4-mg dose group demonstrated statistically significant (P < 
0.0001) weight-bearing asymmetry between hindlimbs through-
out the study (Figure 6). A dose relationship (P < 0.05) for static 
weight-bearing asymmetry was observed between the 1.2-and 
4-mg dose groups for all time points except week 1. Qualita-
tively, the static weight-bearing time series demonstrated an 
inverse relationship between hindlimbs of the same dosage 
group, with a tendency toward unloading of weight from the 
MIA-injected hindlimb to the contralateral control hindlimb 
(Figure 6).
General outcomes. Over the course of the 12-wk study, no 
animal required preemptive euthanasia, none lost the ability 
to ambulate independently, and none demonstrated clinically 
significant weight loss. One animal in the 40-mg dose group 
required analgesic intervention. Multivariate, ANOVA-type 
analysis28 showed that time, as an independent factor, was not 
correlated with the observed changes in locomotor pain behav-
ior for overt lameness, kinetic weight bearing, or static weight 
bearing, whereas MIA dose was found to be a significant factor 
(Table 1). Control animals receiving sham injection in one knee, 
contralateral to a noninjected hindlimb, showed no significant 
difference in kinetic or static weight bearing over the course of 
the study.
Figure 6. Quantitation of static weight bearing by using the force plate system reveals early asymmetry and hindlimb weight transfer in the 
lowest monoiodoacetate (MIA) dose groups. Time series depicts static weight bearing before and after osteoarthritis induction (study week 0). 
Individual data points represent the weekly mean static weight bearing value for each hindlimb per dose group. Open symbols indicate the 
control hindlimb located contralateral to the MIA-injected hindlimb per animal, indicated by closed symbols, for animals that received 1.2 mg 
MIA (red, n = 9 hindlimbs) or 4 mg MIA (green, n = 12 hindlimbs). Static weight bearing was calculated as the percentage of total body weight 
(% TBW) transmitted to each hindlimb calculated as vertical ground reaction force divided by TBW, performed independently for each limb. 
Data are given as mean ± 1 SE. The Student t test was used to determine significant differences in static weight bearing between hindlimbs within 
dose groups. Tukey multiple comparison test was used to determine significant differences in static weight bearing of MIA-injected hindlimbs 
between dose groups. *, P < 0.05; †, P < 0.01; ‡, P < 0.001; §, P < 0.0001.
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Discussion
The induction of osteoarthritis in the swine knee joint by us-
ing intraarticular MIA resulted in detectable locomotor pain 
behaviors compared with controls, allowing for rejection of the 
null hypothesis. The onset of behavioral change occurred by 2 
to 4 wk after osteoarthritis induction, with phenotypes remain-
ing stable thereafter for at least 12 wk. Thus, as an experimental 
outcome, locomotor pain behaviors demonstrated greater stabil-
ity than grading of structural MRI sequences, which revealed 
relentless progression of osteoarthritis over the same time pe-
riod.28 In contrast, time, as an independent factor, did not cor-
relate with observed locomotor pain behaviors. Although the 
induced lameness was evident through live categorical observa-
tion and quantitative kinetic weight bearing, static weight bear-
ing provided the greatest sensitivity to locomotor pain behavior 
at the lowest MIA doses. These findings therefore support the 
use of this large animal model of chronic locomotor pain for 
testing of new treatment strategies for osteoarthritis-related syn-
dromes.
Live observation on an ordinal scale was found to be sensi-
tive in the detection of gait abnormality, discriminating treated 
pigs from controls by 3 to 4 wk after MIA administration and 
showing relative stability throughout serial assessment after 
6 wk. Quantitative gait analysis showed increased sensitivity 
in the detection of progressive behavioral changes during the 
6- to 12-wk period, with less stability of measurement and more 
interindividual variability. Neither live observation nor gait 
analysis could discriminate locomotor pain behaviors between 
the lowest MIA dose group (1.2 mg) and control animals or be-
tween the 2 highest doses (12 and 40 mg MIA). In contrast, static 
weight bearing identified subtle differences between hindlimb 
weight-bearing in the 2 lowest dose groups (1.2 and 4.0 mg 
MIA). Taken together, analysis of locomotor pain behavior by 
lameness assessment, kinetic weight bearing, and static weight 
bearing suggested a dose–response relationship, wherein mild, 
moderate, and severe locomotor pain behaviors could be de-
tected, approximating the range of MIA doses tested.
In addition to improved sensitivity of weight-bearing change, 
the FP system provided ease of use. Gait analysis required as 
much as 20 min of effort by 2 experimentalists to acquire 15 min 
of raw kinetic gait data from one animal. For 15 min of data 
capture from one animal, the FP system required less than 5 
min of preparation. However, the combination of these kinetic 
measurement tools to detect osteoarthritis-associated locomotor 
pain was critical in characterizing the behavioral phenotype of 
this model, and both assays should be used in concert for future 
investigations in treatment effect.
Limitations in the present study were due to the resource-
intensive nature of large animal experimentation. The study 
limitations included small group sizes, observation limited to 
12 wk, differences in dose group sizes, and availability of the 
FP system for testing the lowest 2 MIA dose groups (1.2 and 4 
mg) only. These factors diminished the statistical power of the 
model and, as a result, limited the ability to resolve differences 
between dose groups throughout study weeks. Therefore, if 
significant interactions existed between time, dose group, and 
the key variables of lameness, kinetic weight bearing, and static 
weight bearing, those interactions were likely missed. For these 
reasons, reference to study week throughout this report is used 
to direct the reader to descriptive observations within specific 
study periods and not to a trend over time.
The use of chemically induced models of osteoarthritis has 
been criticized for the rapid onset of disease compared with the 
slowly progressive nature of human osteoarthritis.26 However, 
rapid onset combined with stability of the resulting disease phe-
notype allows for reproducible assessment of treatment effects 
in relieving locomotor pain between cohorts. The present study 
reflects the phenotype described in rodents, where osteoarthritis 
therapeutic testing is common.4,12,18 Recent investigations into 
the homology between MIA-induced osteoarthritic rodent car-
tilage and human osteoarthritic cartilage found little transcrip-
tional similarity between the 2 disease states.2 The phylogenetic 
similarity between humans and swine underlies their distinct 
advantage over rodents,1,30 and MIA-induced cartilage damage 
at a molecular level in swine may be more similar to osteoar-
thritic cartilage damage in humans, although no studies have 
tested this theory.
Demonstration of nocifensive reversal by existing analgesics, 
to benchmark future strategies, was not included in the present 
study, which focused on determining optimal MIA doses for 
causing clinically detectable locomotor pain while document-
ing the natural history of the disease model. The present study 
results will support the design of well-powered treatment stud-
ies, including benchmarking with reference drugs by focusing 
on only 1 or 2 dose levels of MIA.
In summary, we have described a novel large animal model 
of MIA-induced chronic knee osteoarthritis with measurable 
locomotor pain. Kinetic measurement tools, including quantita-
tive gait analysis, static weight bearing, and subjective lame-
ness evaluation, were used in concert to develop this behavioral 
phenotype. Studies combining the locomotor pain quantitation 
tools used here along with subjective comprehensive pain as-
sessment (such as use of a modified visual-analog scale) could 
further describe chronic osteoarthritis pain in this model.
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